AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that three abstracts have been accepted for presentation at the American Society of Nephrology (ASN) Renal Week meeting being held October 27-November 1, 2009 in San Diego, CA. Full abstracts can now be viewed on the ASN website at www.asn-online.org.
The three accepted abstracts are as follows:
- “Hemoglobin Response by Baseline Hemoglobin and Iron Indices Following IV Ferumoxytol Treatment in Nondialysis CKD Patients” (Bolton et al.) – Abstract # 1088: Poster presentation;
10 am-12 pm, Friday, October 30, 2009
- “Gastrointestinal Tolerability of IV Ferumoxytol and Oral Iron Therapy in Patients with Iron Deficiency Anemia and Chronic Kidney Disease” (Spinowitz et al.) – Abstract #1093: Poster presentation; 10 am-12 pm, Friday, October 30, 2009
- “MRI-Based Renal Imaging with Ferumoxytol: Perfusion-Enhanced MRI in a Rabbit Model” (Lewis et al.) – Abstract #2979: Poster presentation; 10 am-12 pm, Saturday, October 31, 2009